About Jason Pontin
Jason Pontin is a director at Proxima Bio.
Form D filings also name Jason Pontin as a director at Relation Therapeutics and Kanvas Biosciences.
Jason Pontin first appears on SEC filings in 2022.
Experience
This experience comes from Jason Pontin's profile and from SEC filings. For roles taken from filings, the years are when the filings name Jason Pontin in the role, so the role may have started earlier or lasted longer.
Proxima Bio, Inc. Current
Director
2026 – Present · New York, NY
Develops AI drug discovery tools and medicines for pharmaceutical research.
CA
Callosum Current
Board Observer
2026 – Present
UC
University of Cambridge Current
Global Advisory Board, Cambridge Innovation Hub
2026 – Present
DL
Dayhoff Labs Current
Board Member
2025 – Present
DC
DCVC Current
General Partner
2021 – Present
TM
Totus Medicines Current
Founding Board Member, Cofounder, and Initial Investor (through Social Impact Capital)
2019 – Present
WI
WIRED Current
Contributing Writer
2018 – Present
RE
Recycleye
Board Member
2023 – 2026
AT
Aquafortus Technologies
Board Member
2023 – 2026
ZW
ZwitterCo
Board Chair
2022 – 2026
EL
Evonetix Ltd
Board Member
2021 – 2026
DM
DVLP Medicines
Board Chair
2022 – 2025
EI
Equilibr.io Inc
Board Chair
2021 – 2025
ST
Strateos
Board Chair
2021 – 2024
AL
Adlai Nortye Biopharma Co., Ltd.
Scientific Advisory Board Member
2020 – 2023
MA
Menten AI
Board Observer and Seed Investor (through Social Impact Capital)
2020 – 2022
VA
Valo
Strategic Advisor
2019 – 2020
FP
Flagship Pioneering
Senior Advisor
2018 – 2020
Key Colleagues at Startups
The people Jason Pontin works with at each company, as listed on that company's latest Form D.
Proxima Bio, Inc. · Form D/A, Jun 10, 2026
Relation Therapeutics Inc. · Form D, Dec 9, 2025
DR
David Roblin
Executive officer and director
CR
Charles Roberts
Director
JM
Jim Mellon
Director
CA
Christine Aylward
Director
CS
Casey Swerner
President
Kanvas Biosciences, Inc. · Form D, Mar 18, 2024